Xtant Medical Stock Target Price and Analyst Consensus

XTNT Stock  USD 0.89  0.02  2.20%   
The current analyst and expert consensus on Xtant Medical is Strong Buy, with 2 strong buy opinions. The current projected Xtant Medical target price consensus is 1.35 with 2 analyst opinions. The most common way Xtant Medical Holdings analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Xtant Medical executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Xtant Medical. We encourage you to use your own analysis of Xtant Medical Holdings to validate this buy or sell advice. Xtant Medical buy-or-sell recommendation module provides average expert sentiment on the projected Xtant Medical Holdings target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Xtant Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
1.23
Highest Forecast
1.5
Target Price
1.35
Net Profit Margin is likely to gain to 0.01 in 2024, whereas Gross Profit is likely to drop slightly above 34 M in 2024. At this time, Xtant Medical's Property Plant And Equipment Gross is comparatively stable compared to the past year. Accumulated Other Comprehensive Income is likely to gain to about 30.4 K in 2024, whereas Net Debt is likely to drop slightly above 16.8 M in 2024.
  
It's important to approach Xtant Medical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Xtant Medical price targets

Xtant Medical's stock target price is an estimate of its future price, usually made by analysts. Using Xtant Medical's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Xtant Medical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Xtant Medical's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Xtant Medical Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Xtant Medical is a key component of Xtant Medical valuation and have some predictive power on the future returns of a Xtant Medical.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Xtant Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.895.96
Details
Intrinsic
Valuation
LowRealHigh
0.051.086.15
Details
Naive
Forecast
LowNextHigh
0.020.935.99
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.02-0.01-0.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Xtant Medical. Your research has to be compared to or analyzed against Xtant Medical's peers to derive any actionable benefits. When done correctly, Xtant Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Xtant Medical Holdings.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Impulse Idea
Impulse
Invested over 100 shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
When determining whether Xtant Medical Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Xtant Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Xtant Medical Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Xtant Medical Holdings Stock:
Check out Macroaxis Advice on Xtant Medical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Xtant Stock analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
The data published in Xtant Medical's official financial statements usually reflect Xtant Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Xtant Medical Holdings. For example, before you start analyzing numbers published by Xtant accountants, it's critical to develop an understanding of what Xtant Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Xtant Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xtant Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Xtant Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Xtant Medical Holdings. Please utilize our Beneish M Score to check the likelihood of Xtant Medical's management manipulating its earnings.